Fibrocytes a new target in interstitial lung disease

R. Strieter (Charlottesville, United States of America)

Source: Annual Congress 2009 - Fibrocytes: a key player in fibrotic airway and pulmonary diseases
Session: Fibrocytes: a key player in fibrotic airway and pulmonary diseases
Session type: Hot topics
Number: 328
Disease area: Interstitial lung diseases

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Strieter (Charlottesville, United States of America). Fibrocytes a new target in interstitial lung disease. Annual Congress 2009 - Fibrocytes: a key player in fibrotic airway and pulmonary diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Circulating fibrocytes in interstitial lung disease
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008

B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Biomarkers for interstitial lung disease
Source: International Congress 2016 – ME1 Biomarkers for interstitial lung disease
Year: 2016



Rituximab in severe, treatment-refractory interstitial lung disease
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Alveoscopy in diffuse interstitial lung disease
Source: Eur Respir J 2007; 30: Suppl. 51, 244s
Year: 2007

Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases
Source: Eur Respir J, 55 (3) 1900933; 10.1183/13993003.00933-2019
Year: 2020



¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


Nitrofurantoin-induced interstitial lung disease
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012

The role of macrophages in interstitial lung diseases
Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017
Year: 2017



IGFBP-2 a new interesting target in IPF
Source: International Congress 2016 – ILD pathogenesis
Year: 2016

Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013


Circulating monocytes from interstitial lung disease patients show an activated phenotype
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Pertechnegas lung clearance in different forms of interstitial lung disease
Source: Eur Respir J 2002; 19: 31-36
Year: 2002



Rituximab in severe, progressive interstitial lung disease
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Looking for airways periostin in patients with interstitial lung diseases.
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018


A clinicopathological review of interstitial pneumonia with marked IgG4 positive plasma cells infiltration
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Interstitial lung disease
Source: School Course 2012 - Thoracic Imaging
Year: 2012